CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Kang, Hong Soon ^a   Liao, Grace ^a   DeGraff, Laura M ^a   Gerrish, Kevin ^a   Bortner, Carl D ^b   Garantziotis, Stavros ^a   Jetten, Anton M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COLLAGEN; GLUCOSE; INSULIN; MATRIX METALLOPROTEINASE; OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL INFILTRATION; COLLAGEN GENE; CONTROLLED STUDY; FATTY LIVER; FIBROGENESIS; GENE EXPRESSION REGULATION; GENETIC MARKER; HEPATITIS; INFLAMMATORY DISEASE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID STORAGE; MACROPHAGE; MALE; MATRIX METALLOPROTEINASE GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OSTEOPONTIN GENE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UNINDEXED SEQUENCE; WHITE ADIPOSE TISSUE;

ADIPOSITY; ANIMALS; ANTIGENS, CD3; ANTIGENS, CD44; BODY WEIGHT; DIET, HIGH-FAT; ENZYME ACTIVATION; FATTY LIVER; GENE EXPRESSION PROFILING; INFLAMMATION; INSULIN RESISTANCE; LIVER; LYMPHOCYTES; MALE; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANNICULITIS;

EID: 84874725462     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058417     Document Type: Article

References (61)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
2. Ogden CL, Carroll MD, Kit BK, Flegal KM, (2012) Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 307: 483-490.
3. Hebbard L, George J, (2011) Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 8: 35-44.
4. Samuel VT, Shulman GI, (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871.
5. Fabbrini E, Sullivan S, Klein S, (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679-689.
6. Gregor MF, Hotamisligil GS, (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29: 415-445.
7. Donath MY, Shoelson SE, (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98-107.
8. Lumeng CN, Saltiel AR, (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121: 2111-2117.
9. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, et al. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15: 914-920.
10. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, et al. (2008) Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 7: 496-507.
11. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
12. Johnson P, Ruffell B, (2009) CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 8: 208-220.
13. Toole BP, (2009) Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Clin Cancer Res 15: 7462-7468.
14. Zoller M, (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11: 254-267.
15. Jiang D, Liang J, Noble PW, (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91: 221-264.
16. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, et al. (1996) Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 98: 2403-2413.
17. Hollingsworth JW, Li Z, Brass DM, Garantziotis S, Timberlake SH, et al. (2007) CD44 regulates macrophage recruitment to the lung in lipopolysaccharide-induced airway disease. Am J Respir Cell Mol Biol 37: 248-253.
18. Solis MA, Chen YH, Wong TY, Bittencourt VZ, Lin YC, et al. (2012) Hyaluronan regulates cell behavior: a potential niche matrix for stem cells. Biochem Res Int 2012: 346972.
19. Miletti-Gonzalez KE, Murphy K, Kumaran MN, Ravindranath AK, Wernyj RP, et al. (2012) Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD): MODULATION OF MATRIX METALLOPROTEINASE 9 (MMP-9) TRANSCRIPTION VIA NOVEL PROMOTER RESPONSE ELEMENT. J Biol Chem 287: 18995-19007.
20. Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, et al. (2009) Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes 58: 125-133.
21. Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, et al. (2012) Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A.
22. Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, et al. (1997) CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90: 2217-2233.
23. Kang HS, Okamoto K, Kim YS, Takeda Y, Bortner CD, et al. (2011) Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance. Diabetes 60: 177-188.
24. Zhou Z, Yon Toh S, Chen Z, Guo K, Ng CP, et al. (2003) Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 35: 49-56.
25. Kang HS, Okamoto K, Takeda Y, Beak JY, Gerrish K, et al. (2011) Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis. Physiol Genomics 43: 818-828.
26. Kang HS, Angers M, Beak JY, Wu X, Gimble JM, et al. (2007) Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol Genomics 31: 281-294.
27. Nagle CA, Klett EL, Coleman RA, (2009) Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res 50Suppl: S74-79.
28. Gong J, Sun Z, Li P, (2009) CIDE proteins and metabolic disorders. Curr Opin Lipidol 20: 121-126.
29. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, et al. (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48: 474-486.
30. Guillen N, Navarro MA, Arnal C, Noone E, Arbones-Mainar JM, et al. (2009) Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver. Physiol Genomics 37: 187-198.
31. Chapman J, Miles PD, Ofrecio JM, Neels JG, Yu JG, et al. (2010) Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS One 5: e13959.
32. Zeyda M, Gollinger K, Todoric J, Kiefer FW, Keck M, et al. (2011) Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function. Endocrinology 152: 2219-2227.
33. Fujii H, Kawada N, (2012) Inflammation and fibrogenesis in steatohepatitis. Journal of gastroenterology 47: 215-225.
34. Ouchi N, Parker JL, Lugus JJ, Walsh K, (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97.
35. Buechler C, Wanninger J, Neumeier M, (2011) Adiponectin, a key adipokine in obesity related liver diseases. World journal of gastroenterology: WJG 17: 2801-2811.
36. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, et al. (2002) A central role for JNK in obesity and insulin resistance. Nature 420: 333-336.
37. Kiefer FW, Neschen S, Pfau B, Legerer B, Neuhofer A, et al. (2011) Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 54: 2132-2142.
38. Wan Z, Frier BC, Williams DB, Wright DC, (2012) Epinephrine induces PDK4 mRNA expression in adipose tissue from obese, insulin resistant rats. Obesity (Silver Spring) 20: 453-456.
39. Zheng YH, Tian C, Meng Y, Qin YW, Du YH, et al. (2012) Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. Journal of cellular physiology 227: 127-135.
40. Pivetta E, Scapolan M, Wassermann B, Steffan A, Colombatti A, et al. (2011) Blood-derived human osteoclast resorption activity is impaired by Hyaluronan-CD44 engagement via a p38-dependent mechanism. Journal of cellular physiology 226: 769-779.
41. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, et al. (2008) FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest 118: 2808-2821.
42. Keller P, Petrie JT, De Rose P, Gerin I, Wright WS, et al. (2008) Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem 283: 14355-14365.
43. Zhou L, Xu L, Ye J, Li D, Wang W, et al. (2012) Cidea promotes hepatic steatosis by sensing dietary fatty acids. Hepatology 56: 95-107.
44. Hajri T, Han XX, Bonen A, Abumrad NA, (2002) Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest 109: 1381-1389.
45. Nicholls HT, Kowalski G, Kennedy DJ, Risis S, Zaffino LA, et al. (2011) Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue. Diabetes 60: 1100-1110.
46. Consolo M, Amoroso A, Spandidos DA, Mazzarino MC, (2009) Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). Int J Mol Med 24: 143-152.
47. Hemmann S, Graf J, Roderfeld M, Roeb E, (2007) Expression of MMPs and TIMPs in liver fibrosis- a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46: 955-975.
48. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, et al. (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 117: 902-909.
49. Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D, (2011) An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54: 2185-2197.
50. Nio Y, Yamauchi T, Iwabu M, Okada-Iwabu M, Funata M, et al. (2012) Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice. Diabetologia.
51. Li Y, Jiang D, Liang J, Meltzer EB, Gray A, et al. (2011) Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. The Journal of experimental medicine 208: 1459-1471.
52. Kitade H, Sawamoto K, Nagashimada M, Inoue H, Yamamoto Y, et al. (2012) CCR5 Plays a Critical Role in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Regulating Both Macrophage Recruitment and M1/M2 Status. Diabetes.
53. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
54. Schenk S, Saberi M, Olefsky JM, (2008) Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 118: 2992-3002.
55. Hursting SD, Hursting MJ, (2012) Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler Thromb Vasc Biol 32: 1766-1770.
56. Li L, Wu LL, (2012) Adiponectin and interleukin-6 in inflammation-associated disease. Vitam Horm 90: 375-395.
57. Shevde LA, Das S, Clark DW, Samant RS, (2010) Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med 10: 71-81.
58. Morimoto J, Kon S, Matsui Y, Uede T, (2010) Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets 11: 494-505.
59. Nakamachi T, Nomiyama T, Gizard F, Heywood EB, Jones KL, et al. (2007) PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes. Diabetes 56: 1662-1670.
60. Nystrom T, Duner P, Hultgardh-Nilsson A, (2007) A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp Cell Res 313: 1149-1160.
61. Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, et al. (2004) Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J Cell Physiol 198: 155-167.